Abstract
Allele and antigen-specific treatment of rheumatoid arthritis: a double blind, placebo controlled phase 1 trial.
Arthur Kavanaugh, Mark Genovese, Jan Baughman, Alan Kivitz, Ken Bulpitt, Nancy Olsen, Michael Weisman, Eric Matteson, Daniel Furst, Ronald van Vollenhoven, James Anderson, Stanley Cohen, Nathan Wei, Jan Meijerink, Cindy Jacobs and Simonetta Mocci
The Journal of Rheumatology March 2003, 30 (3) 449-454;
Arthur Kavanaugh
Mark Genovese
Jan Baughman
Alan Kivitz
Ken Bulpitt
Nancy Olsen
Michael Weisman
Eric Matteson
Daniel Furst
Ronald van Vollenhoven
James Anderson
Stanley Cohen
Nathan Wei
Jan Meijerink
Cindy Jacobs
In this issue
Allele and antigen-specific treatment of rheumatoid arthritis: a double blind, placebo controlled phase 1 trial.
Arthur Kavanaugh, Mark Genovese, Jan Baughman, Alan Kivitz, Ken Bulpitt, Nancy Olsen, Michael Weisman, Eric Matteson, Daniel Furst, Ronald van Vollenhoven, James Anderson, Stanley Cohen, Nathan Wei, Jan Meijerink, Cindy Jacobs, Simonetta Mocci
The Journal of Rheumatology Mar 2003, 30 (3) 449-454;
Allele and antigen-specific treatment of rheumatoid arthritis: a double blind, placebo controlled phase 1 trial.
Arthur Kavanaugh, Mark Genovese, Jan Baughman, Alan Kivitz, Ken Bulpitt, Nancy Olsen, Michael Weisman, Eric Matteson, Daniel Furst, Ronald van Vollenhoven, James Anderson, Stanley Cohen, Nathan Wei, Jan Meijerink, Cindy Jacobs, Simonetta Mocci
The Journal of Rheumatology Mar 2003, 30 (3) 449-454;